The expression of claudin 1 correlates with β-catenin and is a prognostic factor of poor outcome in gastric cancer.

Claudin 1 is one of the tight junction proteins, which are critical in the maintenance of epithelial integrity. Aberrant regulation of CLDN1 and its correlation with β-catenin have been discovered in malignant tumors. The present study aimed to investigate the expression profile and clinical relevance of CLDN1 and β-catenin. The protein levels of CLDN1 and β-catenin were examined using immunohistochemical staining. The characteristics of expression profile and prognostic value were analyzed using Pearson's χ² test and Kaplan-Meier analysis, respectively. β-catenin overexpression and knockdown were used to investigate its role in regulating CLDN1 expression. We showed that CLDN1 was overexpressed in intestinal-type, presence of lymph node metastasis, higher TNM stage in gastric cancer patients and correlated with decreased overall survival. The characteristics of CLDN1 expression were associated with that of β-catenin. CLDN1 and β-catenin showed similar prognostic value in intestinal-type gastric cancers. β-catenin knockdown and overexpression in cell models revealed a positive relation between CLDN1 and β-catenin. Our study demonstrated that CLDN1 is a biomarker for intestinal-type gastric cancer with shorter survival. The expression of CLDN1 was strongly associated with β-catenin in gastric cancer patients and a gastric cancer cell model.

[1]  A. Bhat,et al.  Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. , 2013, Carcinogenesis.

[2]  Takuya Suzuki,et al.  Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells. , 2013, Molecular nutrition & food research.

[3]  G. Giamas,et al.  Claudin-1 as a promoter of EMT in hepatocellular carcinoma , 2013, Oncogene.

[4]  G. Yoon,et al.  Claudin-1 induces epithelial–mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells , 2013, Oncogene.

[5]  A. Hokama,et al.  Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. , 2013, World journal of gastroenterology.

[6]  Wei Wang,et al.  Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer , 2013, PloS one.

[7]  M. Washington,et al.  Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling , 2013, Gut.

[8]  L. Murphy,et al.  Claudin 1 expression in basal-like breast cancer is related to patient age , 2013, BMC Cancer.

[9]  W. Qin,et al.  MicroRNA‐155 is a novel suppressor of ovarian cancer‐initiating cells that targets CLDN1 , 2013, FEBS letters.

[10]  Z. Zhan,et al.  Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma , 2013, Journal of Cardiothoracic Surgery.

[11]  C. Chai,et al.  The expression and significance of WWOX and β‐catenin in hepatocellular carcinoma , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  P. Dhawan,et al.  Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner. , 2012, Carcinogenesis.

[13]  M. Washington,et al.  Caudal Homeobox Protein Cdx-2 Cooperates with Wnt Pathway to Regulate Claudin-1 Expression in Colon Cancer Cells , 2012, PloS one.

[14]  K. Shirouzu,et al.  Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. , 2012, Anticancer research.

[15]  Mingyao Liu,et al.  Claudin 1 Mediates TNFα-Induced Gene Expression and Cell Migration in Human Lung Carcinoma Cells , 2012, PloS one.

[16]  C. Du,et al.  Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: A comparative analysis of three subgroups , 2012, Journal of surgical oncology.

[17]  X. Chen,et al.  Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. , 2011, Gastroenterology.

[18]  U. Cobanoglu,et al.  Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas. , 2011, Pathology, research and practice.

[19]  L. Montaño,et al.  Claudin-6, 7, or 9 Overexpression in the Human Gastric Adenocarcinoma Cell Line AGS Increases Its Invasiveness, Migration, and Proliferation Rate , 2011, Cancer investigation.

[20]  E. Leygue,et al.  Claudin 1 in Breast Tumorigenesis: Revelation of a Possible Novel “Claudin High” Subset of Breast Cancers , 2010, Journal of biomedicine & biotechnology.

[21]  X Chen,et al.  HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability , 2010, Oncogene.

[22]  G. Yoon,et al.  Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver Cells* , 2009, The Journal of Biological Chemistry.

[23]  Hyun Cheol Chung,et al.  Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer , 2009, PLoS genetics.

[24]  W. Hohenberger,et al.  Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. , 2009, Experimental and molecular pathology.

[25]  L. Murphy,et al.  Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype , 2009, Virchows Archiv.

[26]  Sung-Liang Yu,et al.  Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. , 2009, American journal of respiratory and critical care medicine.

[27]  S. Zhang,et al.  Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. , 2008, World journal of gastroenterology.

[28]  R. Mrsny,et al.  A key claudin extracellular loop domain is critical for epithelial barrier integrity. , 2008, The American journal of pathology.

[29]  J. Moldvay,et al.  Distinct claudin expression profile in histologic subtypes of lung cancer. , 2007, Lung cancer.

[30]  H. Kijima,et al.  Decreased expression of claudin-1 correlates with recurrence status in breast cancer. , 2007, International journal of molecular medicine.

[31]  Y. Matsuda,et al.  Gastric and intestinal claudin expression at the invasive front of gastric carcinoma , 2007, Cancer science.

[32]  M. Washington,et al.  Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. , 2007, Cancer research.

[33]  S. Moss,et al.  Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. , 2005, Human pathology.

[34]  M. Washington,et al.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. , 2005, The Journal of clinical investigation.

[35]  N. Sawada,et al.  Occludin expression decreases with the progression of human endometrial carcinoma. , 2004, Human pathology.

[36]  S. Tsukita,et al.  Claudin-based barrier in simple and stratified cellular sheets. , 2002, Current opinion in cell biology.

[37]  J. Lee,et al.  bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. , 1995, Cancer research.

[38]  M. Salto‐Tellez,et al.  Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. , 2010, Gastroenterology.

[39]  I. Sporea,et al.  Gastric cancer: correlation between clinicopathological factors and survival of patients (III). , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[40]  I. Sporea,et al.  Gastric cancer: correlation between clinicopathological factors and survival of patients. II. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[41]  Hermann Brenner,et al.  Epidemiology of stomach cancer. , 2009, Methods in molecular biology.

[42]  H. Helin,et al.  Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype , 2005, Virchows Archiv.

[43]  N. Niikawa,et al.  Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. , 2001, Oncology research.